Home/Filings/4/0001721515-25-000014
4//SEC Filing

Moschner Matthew 4

Accession 0001721515-25-000014

CIK 0000851205other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:23 PM ET

Size

38.0 KB

Accession

0001721515-25-000014

Insider Transaction Report

Form 4
Period: 2018-02-20
Moschner Matthew
Senior Vice President
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2024-02-20+58,26058,260 total
    Exercise: $39.44From: 2025-02-20Exp: 2034-02-20Common Stock (58,260 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2018-11-19+4,0004,000 total
    Exercise: $40.71From: 2019-11-19Exp: 2028-11-19Common Stock (4,000 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2018-10-31+7,0007,000 total
    Exercise: $42.84From: 2021-10-31Exp: 2028-10-31Common Stock (7,000 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2023-02-21+37,83237,832 total
    Exercise: $47.21From: 2024-02-21Exp: 2033-02-21Common Stock (37,832 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-08-04+35,63935,639 total
    Exercise: $47.95From: 2026-08-04Exp: 2032-08-04Common Stock (35,639 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2023-08-07+47,96247,962 total
    Exercise: $50.01From: 2027-08-07Exp: 2033-08-07Common Stock (47,962 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-02-19+4,0004,000 total
    Exercise: $51.49From: 2020-02-19Exp: 2029-02-19Common Stock (4,000 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2019-10-30+9,0009,000 total
    Exercise: $51.97From: 2020-10-30Exp: 2029-10-30Common Stock (9,000 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2018-02-20+1,6001,600 total
    Exercise: $56.44From: 2019-02-20Exp: 2028-02-20Common Stock (1,600 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2021-08-09+8,4268,426 total
    Exercise: $86.38From: 2025-08-09Exp: 2031-08-09Common Stock (8,426 underlying)
  • Award

    Restricted Stock Unit

    2022-02-22+1,5521,552 total
    Exercise: $0.00From: 2023-02-22Exp: 2025-02-22Common Stock (1,552 underlying)
  • Award

    Restricted Stock Unit

    2022-08-04+3,4413,441 total
    Exercise: $0.00From: 2023-08-04Exp: 2025-08-04Common Stock (3,441 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2025-02-18+68,82368,823 total
    Exercise: $33.04From: 2026-02-18Exp: 2035-02-18Common Stock (68,823 underlying)
  • Award

    Restricted Stock Unit

    2023-02-21+5,5925,592 total
    Exercise: $0.00From: 2024-02-21Exp: 2026-02-21Common Stock (5,592 underlying)
  • Award

    Restricted Stock Unit

    2023-08-07+7,9997,999 total
    Exercise: $0.00From: 2024-08-07Exp: 2026-08-07Common Stock (7,999 underlying)
  • Award

    Restricted Stock Unit

    2024-02-20+10,14210,142 total
    Exercise: $0.00From: 2025-02-20Exp: 2027-02-20Common Stock (10,142 underlying)
  • Award

    Restricted Stock Unit

    2025-02-18+25,42425,424 total
    Exercise: $0.00From: 2026-02-18Exp: 2028-02-18Common Stock (25,424 underlying)
Footnotes (3)
  • [F1]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
  • [F3]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.

Issuer

COGNEX CORP

CIK 0000851205

Entity typeother

Related Parties

1
  • filerCIK 0002054688

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:23 PM ET
Size
38.0 KB